PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp (PRCT)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -31,638 | -29,845 | -21,411 | -44,316 |
| Depreciation and amortization | 1,735 | 1,709 | 1,618 | 3,063 |
| Stock-based compensation expense | 13,072 | 10,842 | 14,490 | 22,271 |
| Change in fair value in derivative liability | NaN | 0 | 0 | 0 |
| Non-cash lease adjustment | 159 | 127 | 127 | 254 |
| Provision for credit losses | 195 | -1 | 76 | 490 |
| Inventory write-down | 274 | -1,207 | 526 | 900 |
| (gain) loss on foreign currency transactions | NaN | -157 | NaN | NaN |
| Loss on foreign currency transactions | -418 | NaN | -227 | 348 |
| Reimbursements for leasehold improvements from operating leases | NaN | 0 | 0 | 0 |
| Accounts receivable, net | 13,317 | -2,230 | 4,351 | -1,223 |
| Inventory | 7,027 | 3,998 | -568 | 11,068 |
| Prepaid expenses and other current assets | -1,167 | 431 | 1,760 | -1,089 |
| Other assets | 431 | 922 | 808 | 1,165 |
| Accounts payable | 1,536 | 5,933 | -789 | 1,504 |
| Accrued compensation | -4,688 | 1,383 | 5,455 | -5,248 |
| Accrued interest expense | 49 | 48 | 42 | 52 |
| Loan facility liability | NaN | 0 | 0 | -2,000 |
| Deferred revenue | 628 | 1,954 | 1,129 | 223 |
| Other liabilities | 180 | 1,827 | -1,520 | 1,561 |
| Net cash used in operating activities | -38,127 | -10,327 | -6,635 | -32,023 |
| Purchases of property and equipment | 2,914 | 1,850 | 2,868 | 4,638 |
| Net cash used in investing activities | -2,914 | -1,850 | -2,868 | -4,638 |
| Proceeds from issuance of common stock under employee stock purchase plan | NaN | 6,362 | NaN | NaN |
| Proceeds from issuance of common stock from the exercise of stock options | 222 | 1,582 | 1,078 | 2,171 |
| Proceeds from issuance of common stock under employee stock purchase plan | NaN | NaN | -1 | 3,505 |
| Proceeds from issuance of common stock, net of issuance costs | NaN | 0 | NaN | NaN |
| Net cash provided by financing activities | 222 | 4,440 | 1,077 | 5,676 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | -42 | -41 | -10 | -23 |
| Net decrease in cash, cash equivalents and restricted cash | -40,861 | -7,778 | -8,436 | -31,008 |
| Beginning of the period | 289,540 | 39,444 | 336,763 | NaN |
| End of the period | 248,679 | -7,778 | 297,319 | NaN |